Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease.

The liver plays a key role in amino acid metabolism. In former studies, a ratio between branched-chain and aromatic amino acids (Fischer's ratio) revealed associations with hepatic encephalopathy. Furthermore, low concentrations of branched-chain amino acids were linked to sarcopenia in literat...

Full description

Bibliographic Details
Main Authors: Benedict Kinny-Köster, Michael Bartels, Susen Becker, Markus Scholz, Joachim Thiery, Uta Ceglarek, Thorsten Kaiser
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4943589?pdf=render
_version_ 1818477119529811968
author Benedict Kinny-Köster
Michael Bartels
Susen Becker
Markus Scholz
Joachim Thiery
Uta Ceglarek
Thorsten Kaiser
author_facet Benedict Kinny-Köster
Michael Bartels
Susen Becker
Markus Scholz
Joachim Thiery
Uta Ceglarek
Thorsten Kaiser
author_sort Benedict Kinny-Köster
collection DOAJ
description The liver plays a key role in amino acid metabolism. In former studies, a ratio between branched-chain and aromatic amino acids (Fischer's ratio) revealed associations with hepatic encephalopathy. Furthermore, low concentrations of branched-chain amino acids were linked to sarcopenia in literature. Encephalopathy and sarcopenia are known to dramatically worsen the prognosis. Aim of this study was to investigate a complex panel of plasma amino acids in the context of mortality in patients with end-stage liver disease.166 patients evaluated for orthotopic liver transplantation were included. 19 amino acids were measured from citrated plasma samples using mass spectrometry. We performed survival analysis for plasma amino acid constellations and examined the relationship to established mortality predictors.33/166 (19.9%) patients died during follow-up. Lower values of valine (p<0.001), Fischer's ratio (p<0.001) and valine to phenylalanine ratio (p<0.001) and higher values of phenylalanine (p<0.05) and tyrosine (p<0.05) were significantly associated with mortality. When divided in three groups, the tertiles discriminated cumulative survival for valine (p = 0.016), phenylalanine (p = 0.024) and in particular for valine to phenylalanine ratio (p = 0.003) and Fischer's ratio (p = 0.005). Parameters were also significantly correlated with MELD and MELD-Na score.Amino acids in plasma are valuable biomarkers to determine increased risk of mortality in patients with end-stage liver disease. In particular, valine concentrations and constellations composed of branched-chain and aromatic amino acids were strongly associated with prognosis. Due to their pathophysiological importance, the identified amino acids could be used to examine individual dietary recommendations to serve as potential therapeutic targets.
first_indexed 2024-12-10T09:34:05Z
format Article
id doaj.art-ab30a972dd9646b49d6160f7fb5a1ea3
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T09:34:05Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ab30a972dd9646b49d6160f7fb5a1ea32022-12-22T01:54:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01117e015920510.1371/journal.pone.0159205Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease.Benedict Kinny-KösterMichael BartelsSusen BeckerMarkus ScholzJoachim ThieryUta CeglarekThorsten KaiserThe liver plays a key role in amino acid metabolism. In former studies, a ratio between branched-chain and aromatic amino acids (Fischer's ratio) revealed associations with hepatic encephalopathy. Furthermore, low concentrations of branched-chain amino acids were linked to sarcopenia in literature. Encephalopathy and sarcopenia are known to dramatically worsen the prognosis. Aim of this study was to investigate a complex panel of plasma amino acids in the context of mortality in patients with end-stage liver disease.166 patients evaluated for orthotopic liver transplantation were included. 19 amino acids were measured from citrated plasma samples using mass spectrometry. We performed survival analysis for plasma amino acid constellations and examined the relationship to established mortality predictors.33/166 (19.9%) patients died during follow-up. Lower values of valine (p<0.001), Fischer's ratio (p<0.001) and valine to phenylalanine ratio (p<0.001) and higher values of phenylalanine (p<0.05) and tyrosine (p<0.05) were significantly associated with mortality. When divided in three groups, the tertiles discriminated cumulative survival for valine (p = 0.016), phenylalanine (p = 0.024) and in particular for valine to phenylalanine ratio (p = 0.003) and Fischer's ratio (p = 0.005). Parameters were also significantly correlated with MELD and MELD-Na score.Amino acids in plasma are valuable biomarkers to determine increased risk of mortality in patients with end-stage liver disease. In particular, valine concentrations and constellations composed of branched-chain and aromatic amino acids were strongly associated with prognosis. Due to their pathophysiological importance, the identified amino acids could be used to examine individual dietary recommendations to serve as potential therapeutic targets.http://europepmc.org/articles/PMC4943589?pdf=render
spellingShingle Benedict Kinny-Köster
Michael Bartels
Susen Becker
Markus Scholz
Joachim Thiery
Uta Ceglarek
Thorsten Kaiser
Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease.
PLoS ONE
title Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease.
title_full Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease.
title_fullStr Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease.
title_full_unstemmed Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease.
title_short Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease.
title_sort plasma amino acid concentrations predict mortality in patients with end stage liver disease
url http://europepmc.org/articles/PMC4943589?pdf=render
work_keys_str_mv AT benedictkinnykoster plasmaaminoacidconcentrationspredictmortalityinpatientswithendstageliverdisease
AT michaelbartels plasmaaminoacidconcentrationspredictmortalityinpatientswithendstageliverdisease
AT susenbecker plasmaaminoacidconcentrationspredictmortalityinpatientswithendstageliverdisease
AT markusscholz plasmaaminoacidconcentrationspredictmortalityinpatientswithendstageliverdisease
AT joachimthiery plasmaaminoacidconcentrationspredictmortalityinpatientswithendstageliverdisease
AT utaceglarek plasmaaminoacidconcentrationspredictmortalityinpatientswithendstageliverdisease
AT thorstenkaiser plasmaaminoacidconcentrationspredictmortalityinpatientswithendstageliverdisease